Caldera Medical, Inc. on October 8th, 2024, announced the acquisition of UVision 360, Inc. Caldera Medical develops medical devices for women’s health, including surgical products for the treatment of stress urinary incontinence, pelvic floor disorders, pelvic organ prolapse, and hysteroscopic removal of intrauterine tissue. UVision 360 is a developer of in-office hysteroscopy systems for evaluating and treating uterine conditions.
The acquisition is purported to bolster Caldera Medical’s minimally invasive solutions, particularly in the realm of advanced hysteroscopy and its Benesta® product line. Caldera Medical reports that it expects this acquisition to broaden its portfolio for diagnosis and treatment of polyps, fibroids, and intrauterine pathology through the introduction of UVision 360’s LUMINELLE® technology with the Benesta® line to enhance procedural capabilities for gynecologic surgeons.
The LUMINELLE® DTx Hysteroscopy System reportedly uses separately controlled fluid inflow and outflow, Rotowings enabling 360° rotation, and the RotoSheath’s graduated tip size and hydrodilation from the inflow valve, to assist in hysteroscopy and cystoscopy procedures. UVision 360’s new LUMINELLE® Bx system purports to allow physicians to achieve a more accurate and precise diagnosis through its on-demand biopsy technology with integrated visualization.
Regarding the acquisition, Bryon Merade, CEO of Caldera Medical, stated:
We are excited to integrate LUMINELLE’s technology into Caldera Medical’s growing portfolio. This acquisition strengthens our commitment to offering gynecologic surgeons state-of-the-art tools that streamline hysteroscopic procedures while enhancing patient safety and clinical outcomes.
Caldera Medical’s acquisition of UVision 360 follows Caldera Medical’s announced acquisition of Atlantic Therapeutics, completed in September 2023. Caldera’s acquisition of Atlantic Therapeutics added the Innovo® device to their technology offerings, for treating urinary incontinence for at-home users via electrical muscle stimulation.
Erich Dreyer, co-founder and engineer involved with the LUMINELLE® technology, stated the following about the acquisition:
I’m thrilled to join the talented team at Caldera Medical to expand the commercial reach of the LUMINELLE® portfolio. … With Caldera’s commercial infrastructure and investment in women’s health, we will be able to provide both physicians and patients with a solution to the flawed uterine disease diagnosis market dominated by inaccurate blind biopsies.
A press release regarding the acquisition is available here.
Follow Knobbe Medical for more news and developments in the medical device industry.
Tags
acquisition, Caldera Medical, Cystoscopy, Gynecology, hysteroscopic removal of intrauterine tissue, Hysteroscopy, medical device, pelvic floor disorders, pelvic organ prolapse, stress urinary incontinence, uterine cancer treatment, UVision 360, women's health